The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey-Reference-Cited by-同舟云学术

The current state of clinical mycology in Africa: a European Confederation of Medical Mycology and International Society for Human and Animal Mycology survey

Published:2022-06 Issue:6 Volume:3 Page:e464-e470
ISSN:2666-5247
Container-title:The Lancet Microbe
language:en
Short-container-title:The Lancet Microbe

Author:

Driemeyer Cândida,Falci Diego R,Oladele Rita O,Bongomin Felix,Ocansey Bright K,Govender Nelesh P,Hoenigl Martin,Gangneux Jean Pierre,Lass-Flörl Cornelia,Cornely Oliver A,Alanio Alexandre,Guinea Jesus,Morrissey C Orla,Rautemaa-Richardson Riina,Chakrabarti Arunaloke,Meis Jacques F,Bruns Caroline,Stemler Jannik,Pasqualotto Alessandro C

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference52 articles.

1. COVID-19 pandemic and antiretrovirals (ARV) availability in Nigeria: recommendations to prevent shortages;Dada;Pan Afr Med J,2020

2. The impact of COVID-19 pandemic on AIDS-related mycoses and fungal neglected tropical diseases: why should we worry?;Nargesi;PLoS Negl Trop Dis,2021

3. The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: a Nigerian model;Oladele;Mycoses,2019

4. Bridging the knowledge gap on mycoses in Africa: setting up a Pan-African Mycology Working Group;Oladele;Mycoses,2020

5. Improving outcome of fungal diseases - guiding experts and patients towards excellence;Cornely;Mycoses,2017

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reassessment of the role of combination antifungal therapy in the current era;Current Opinion in Infectious Diseases;2024-09-12

2. Paving the way for affordable and equitable liposomal amphotericin B access worldwide;The Lancet Global Health;2024-09

3. Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained Settings;Open Forum Infectious Diseases;2024-08-27

4. A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole;Medical Mycology;2024-08-13

5. Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate;Journal of Antimicrobial Chemotherapy;2024-08-01